Evaluating Perioperative Dexamethasone and the Risk of Bleeding in Tonsillectomy
Primary Purpose
Post-operative Hemorrhage
Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Dexamethasone
Sponsored by
About this trial
This is an interventional treatment trial for Post-operative Hemorrhage
Eligibility Criteria
Inclusion Criteria:
- Patients ages 3 to 18 undergoing tonsillectomy or adenotonsillectomy by electrocautery alone for the indication of sleep disordered breathing or infectious tonsillitis.
- Patients with complex medical conditions or craniofacial abnormalities will be included.
- Informed consent and child assent are required for enrollment.
- Eligibility will be determined by the principal investigator, associate investigator or research nurse.
Exclusion Criteria:
- Subjects with a known personal or family history of any bleeding disorder will be excluded.
- Subjects currently on oral corticosteroids for other medical conditions or have recently taken any oral corticosteroid within two weeks of surgery.
- Patients with tonsillectomy performed using a cold knife technique, microdebrider, coblation or plasma knife due to surgeon or parent preference.
- Where appropriate subjects who do not have informed consent or child assent signed will be excluded
- Children less than three years old will be excluded due to the fact the majority of these children at the collaborating centers have an adenotonsillectomy using the microdebrider for pain control purposes.
Sites / Locations
- Massachusetts Eye and Ear Infirmary
Arms of the Study
Arm 1
Arm 2
Arm Type
Placebo Comparator
Experimental
Arm Label
Saline
Dexamethasone
Arm Description
Placebo is described in chart
Dexamethasone is described in chart
Outcomes
Primary Outcome Measures
Number of Participants With Post-tonsillectomy Bleeding
Secondary Outcome Measures
Full Information
NCT ID
NCT01415583
First Posted
October 27, 2010
Last Updated
June 12, 2017
Sponsor
Massachusetts Eye and Ear Infirmary
1. Study Identification
Unique Protocol Identification Number
NCT01415583
Brief Title
Evaluating Perioperative Dexamethasone and the Risk of Bleeding in Tonsillectomy
Official Title
Evaluating Perioperative Dexamethasone and the Risk of Bleeding in Tonsillectomy
Study Type
Interventional
2. Study Status
Record Verification Date
June 2017
Overall Recruitment Status
Completed
Study Start Date
July 2010 (Actual)
Primary Completion Date
November 2011 (Actual)
Study Completion Date
November 2011 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Massachusetts Eye and Ear Infirmary
4. Oversight
Data Monitoring Committee
Yes
5. Study Description
Brief Summary
Tonsillectomy (removal of the tonsils) is a very common surgery in children. Bleeding after tonsillectomy is one of the risks of this surgery and can be more dangerous in children since they have less blood volume than adults. In order to improve recovery after tonsillectomy, steroids (medication that is a strong anti-inflammatory) are often given during the surgery. Recently, a study showed steroids given at the time of tonsillectomy increase the risk of bleeding significantly over children who did not receive steroids. This finding has raised concerns in the Ear, Nose, and Throat (ENT) community since most ENT's use steroids during tonsillectomy in children. The investigators look to explore this question further.
To answer the question of whether perioperative steroid administration significantly affects the rate of post-tonsillectomy bleeding, the investigators propose to test the following hypotheses in a prospective, randomized, blinded placebo-controlled trial: dexamethasone does not cause an increase in post-operative bleeding rate in tonsillectomy.
Detailed Description
Detailed description is entered above
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Post-operative Hemorrhage
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
ParticipantInvestigator
Allocation
Randomized
Enrollment
314 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Saline
Arm Type
Placebo Comparator
Arm Description
Placebo is described in chart
Arm Title
Dexamethasone
Arm Type
Experimental
Arm Description
Dexamethasone is described in chart
Intervention Type
Drug
Intervention Name(s)
Dexamethasone
Other Intervention Name(s)
Decadron
Intervention Description
0.5mg/kg (max dose 20mg)
Primary Outcome Measure Information:
Title
Number of Participants With Post-tonsillectomy Bleeding
Time Frame
2 weeks after surgery
10. Eligibility
Sex
All
Minimum Age & Unit of Time
3 Years
Maximum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Patients ages 3 to 18 undergoing tonsillectomy or adenotonsillectomy by electrocautery alone for the indication of sleep disordered breathing or infectious tonsillitis.
Patients with complex medical conditions or craniofacial abnormalities will be included.
Informed consent and child assent are required for enrollment.
Eligibility will be determined by the principal investigator, associate investigator or research nurse.
Exclusion Criteria:
Subjects with a known personal or family history of any bleeding disorder will be excluded.
Subjects currently on oral corticosteroids for other medical conditions or have recently taken any oral corticosteroid within two weeks of surgery.
Patients with tonsillectomy performed using a cold knife technique, microdebrider, coblation or plasma knife due to surgeon or parent preference.
Where appropriate subjects who do not have informed consent or child assent signed will be excluded
Children less than three years old will be excluded due to the fact the majority of these children at the collaborating centers have an adenotonsillectomy using the microdebrider for pain control purposes.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Christopher Hartnick, MD
Organizational Affiliation
Massachusetts Eye and Ear Infirmary
Official's Role
Principal Investigator
Facility Information:
Facility Name
Massachusetts Eye and Ear Infirmary
City
Boston
State/Province
Massachusetts
ZIP/Postal Code
02114
Country
United States
12. IPD Sharing Statement
Plan to Share IPD
No
Citations:
PubMed Identifier
23011712
Citation
Gallagher TQ, Hill C, Ojha S, Ference E, Keamy DG, Williams M, Hansen M, Maurer R, Collins C, Setlur J, Capra GG, Brigger MT, Hartnick CJ. Perioperative dexamethasone administration and risk of bleeding following tonsillectomy in children: a randomized controlled trial. JAMA. 2012 Sep 26;308(12):1221-6. doi: 10.1001/2012.jama.11575.
Results Reference
derived
Learn more about this trial
Evaluating Perioperative Dexamethasone and the Risk of Bleeding in Tonsillectomy
We'll reach out to this number within 24 hrs